‘Healthspan must not remain a privilege of the wealthy; it should become a universal right’ Peter Diamandis addresses healthspan progress, opportunities and challenges ahead of Hevolution’s Global Healthspan Summit. #healthspan #aging #longevity #GlobalHealthspanSummit

Investing in the global race to develop healthspan therapeutics a16z’s Jorge Conde says uncovering ‘unexpected causal relationships’ in biology could define the future of healthspan. #healthspan #investment #biotech #AI

Fauna Bio’s first development candidate targets heart failure Drug emerges from research into cardiac protection mechanisms of hibernating ground squirrels – clinical trial expected in 2026. #longevity #biotech #heartfailure

Oura and Dexcom to combine glucose sensing and wearable health tracking Metabolic health companies join forces as CGM giant pours $75m into smart ring leader, at a valuation of more than $5bn. #longevity #wearables #CGM #glucose #metabolism #investment

Longevity biotech aims to unleash the power of NAD+ against age-related diseases MetaShape’s PNP inhibitor technology aims to restore NAD+ levels to combat LDL cholesterol, cognitive decline and neurodegeneration. #longevity #biotech #NAD+